References
- Andre T, Boni C, Mounedji-Boudiaf L, et al (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 350, 2343-51. https://doi.org/10.1056/NEJMoa032709
- Bajetta E, Pietrantonio F, Di Bartolomeo M, Buzzoni R (2010). Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report. Tumori, 96, 154-6.
- Basu R, Rajkumar A, Datta NR (2002). Anaphylaxis to cisplatin following nine previous uncomplicated cycles. Int J Clin Oncol, 7, 365-7. https://doi.org/10.1007/s101470200056
- Bautista MA, Stevens WT, Chen CS, et al (2010). Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J Hematol Oncol, 3, 12. https://doi.org/10.1186/1756-8722-3-12
- Bhargava P, Gammon D, McCormick MJ (2004). Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer, 100, 211-2. https://doi.org/10.1002/cncr.11901
- Brandi G, Pantaleo MA, Galli C, et al (2003). Hypersensitivity reactions related to oxaliplatin (OHP). Br J Cancer, 89, 477-81. https://doi.org/10.1038/sj.bjc.6601155
- Collet E, Leguy-Seguin V, Jolimoy G, et al (2007). Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immun, 119, 726-30. https://doi.org/10.1016/j.jaci.2006.11.640
- Faivre S, Chan C, Salinas R, et al (2003). DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells. Biochem Pharmacol, 66, 225-37. https://doi.org/10.1016/S0006-2952(03)00260-0
- Garufi C, Cristaudo A, Vanni B, et al (2003). Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol, 14, 497-8. https://doi.org/10.1093/annonc/mdg092
- Gowda A, Goel R, Berdzik J, et al (2004). Hypersensitivity Reactions to oxaliplatin: incidence and management. Oncology, 18, 1671-5; discussion 6, 80, 83-4.
- Ichikawa Y, Goto A, Hirokawa S, et al (2009). Allergic reactions to oxaliplatin in a single institute in Japan. Jpn J Clin Oncol, 39, 616-20. https://doi.org/10.1093/jjco/hyp070
- Kelland L (2007). The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer, 7, 573-84. https://doi.org/10.1038/nrc2167
- Kidera Y, Satoh T, Ueda S, et al (2011). High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin. Int J Clin Oncol, 16, 244-9. https://doi.org/10.1007/s10147-010-0170-6
- Kim BH, Bradley T, Tai J, Budman DR (2009). Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review. Oncology, 76, 231-8. https://doi.org/10.1159/000205263
- Koren C, Yerushalmi R, Katz A, et al (2002). Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy. Am J Clin Oncol, 25, 625-6. https://doi.org/10.1097/00000421-200212000-00020
- Lee KH, Park YJ, Kim ES, et al (2006). Hypersensitivity reactions to oxaliplatin. Cancer Res Treat, 38, 240-1. https://doi.org/10.4143/crt.2006.38.4.240
- Lee MY, Yang MH, Liu JH, et al (2007). Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication. Support Care Cancer, 15, 89-93. https://doi.org/10.1007/s00520-006-0107-9
- Lim KH, Huang MJ, Lin HC, et al. (2004). Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule. Anticancer Drugs, 15, 605-7. https://doi.org/10.1097/01.cad.0000132235.38297.7c
- Maindrault-Goebel F, Andre T, Tournigand C, et al. (2005). Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer, 41, 2262-7. https://doi.org/10.1016/j.ejca.2005.06.021
- Makrilia N, Syrigou E, Kaklamanos I, et al (2010). Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Met Based Drugs, ??, ??.
- Markman M, Kennedy A, Webster K, et al (1999). An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. J Cancer Res Clin Oncol, 125, 427-9. https://doi.org/10.1007/s004320050297
- Mason JM, Rees G (2010). Oxaliplatin-induced acute thrombocytopenia. J Oncol Pharm Pract, 17, 433-5.
- Morgan JS, Adams M, Mason MD (1994). Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma. Eur J Cancer, 30A, 1205-6.
- Petit-Laurent F, Conroy T, Krakowski I, et al (2000). [Delayed urticaria with oxaliplatin]. Gastroenterol Clin Biol, 24, 851-2.
- Polyzos A, Tsavaris N, Gogas H, et al (2009). Clinical features of hypersensitivity reactions to oxaliplatin: a 10- year experience. Oncology, 76, 36-41. https://doi.org/10.1159/000178163
- Polyzos A, Tsavaris N, Kosmas C, et al (2001). Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology, 61, 129-33. https://doi.org/10.1159/000055363
- Santini D, Tonini G, Salerno A, et al (2001). Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol, 12, 132-3. https://doi.org/10.1023/A:1008366223918
- Shao YY, Hu FC, Liang JT, et al. (2010). Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions. J Formos Med Assoc, 109, 362-8. https://doi.org/10.1016/S0929-6646(10)60064-2
- Shibata Y, Ariyama H, Baba E, et al (2009). Oxaliplatininduced allergic reaction in patients with colorectal cancer in Japan. Int J Clin Oncol, 14, 397-401. https://doi.org/10.1007/s10147-009-0883-6
- Siu SW, Chan RT, Au GK (2006). Hypersensitivity reactions to oxaliplatin: experience in a single institute. Ann Oncol, 17, 259-61. https://doi.org/10.1093/annonc/mdl270
- Thomas RR, Quinn MG, Schuler B, Grem JL (2003). Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer, 97, 2301-7. https://doi.org/10.1002/cncr.11379
- Trotti A, Colevas AD, Setser A, et al (2003). CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol, 13, 176-81. https://doi.org/10.1016/S1053-4296(03)00031-6
- Villee C, Tennstedt D, Marot L, et al (2010). Delayed urticaria with oxaliplatin. Contact Dermatitis, 63, 50-3. https://doi.org/10.1111/j.1600-0536.2010.01738.x
- Zanotti KM, Rybicki LA, Kennedy AW, et al (2001). Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol, 19, 3126-9.
Cited by
- Updates on desensitization for hypersensitivity reactions related to chemotherapy vol.1, pp.4, 2013, https://doi.org/10.4168/aard.2013.1.4.295
- Hypersensitivity reactions associated with oxaliplatin and their clinical management vol.13, pp.11, 2014, https://doi.org/10.1517/14740338.2014.963551
- Oxaliplatin vol.1483, pp.1, 2014, https://doi.org/10.1007/s40278-014-8122-y
- Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma vol.3, pp.1, 2014, https://doi.org/10.1186/s40169-014-0028-z